In summary, we have carried out a novel study showing that the hepatic expression of OLFM2 seems to increase as NAFLD progresses, and this protein seems to be associated with NASH and with a severe steatosis pattern in NAFLD patients. The gene discussed is OLFM2; the disease is metabolic dysfunction-associated steatotic liver disease.